Folate Analog Metabolic Inhibitor [EPC]

440072 reported adverse events

Drugs of this class: METHOTREXATE PRALATREXATE PEMETREXED PEMETREXED DIPOTASSIUM

These side effects are most commonly reported by patients taking drugs of the Folate Analog Metabolic Inhibitor [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 77001
1 RHEUMATOID ARTHRITIS 38662
2 ARTHRALGIA 37004
3 OFF LABEL USE 36476
4 PAIN 36222
5 FATIGUE 30457
6 NAUSEA 25558
7 JOINT SWELLING 22691
8 HEADACHE 21526
9 RASH 21051
See all common reactions for Folate Analog Metabolic Inhibitor [EPC]

Drugs of the Folate Analog Metabolic Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 5927 0.8264
1 RHEUMATOID FACTOR POSITIVE 4559 0.7885
2 SWOLLEN JOINT COUNT INCREASED 2456 0.7694
3 PEMPHIGUS 9036 0.7220
4 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 1658 0.7190
5 RHEUMATIC FEVER 3208 0.7190
6 SYNOVITIS 12408 0.6875
7 C-REACTIVE PROTEIN ABNORMAL 4362 0.6793
8 DUODENAL ULCER PERFORATION 4955 0.6656
9 HAND DEFORMITY 8524 0.6492
See all enriched reactions for Folate Analog Metabolic Inhibitor [EPC]